User profiles for "author:Ailsa Sita-Lumsden"
 | Ailsa Sita-Lumsdenconsultant medical oncologist Verified email at gstt.nhs.uk Cited by 1833 |
Reactivation of tuberculosis and vitamin D deficiency: the contribution of diet and exposure to sunlight
A Sita-Lumsden, G Lapthorn, R Swaminathan… - Thorax, 2007 - thorax.bmj.com
Background: As well as its role in the regulation of calcium metabolism, vitamin D is an
immunoregulatory hormone. Epidemiological evidence also suggests a link between vitamin …
immunoregulatory hormone. Epidemiological evidence also suggests a link between vitamin …
Time-dependent COVID-19 mortality in patients with cancer: an updated analysis of the OnCovid registry
Importance Whether the severity and mortality of COVID-19 in patients with cancer have
improved in terms of disease management and capacity is yet to be defined. Objective To …
improved in terms of disease management and capacity is yet to be defined. Objective To …
Androgen-regulated processing of the oncomir miR-27a, which targets Prohibitin in prostate cancer
MicroRNAs (miRs) play an important role in the development of many complex human
diseases and may have tumour suppressor or oncogenic (oncomir) properties. Prostate …
diseases and may have tumour suppressor or oncogenic (oncomir) properties. Prostate …
Outcomes of the SARS-CoV-2 omicron (B. 1.1. 529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the …
Summary Background The omicron (B. 1.1. 529) variant of SARS-CoV-2 is highly
transmissible and escapes vaccine-induced immunity. We aimed to describe outcomes due …
transmissible and escapes vaccine-induced immunity. We aimed to describe outcomes due …
[HTML][HTML] Risk of COVID-19 death in cancer patients: an analysis from Guy's Cancer Centre and King's College Hospital in London
B Russell, CL Moss, V Shah, TK Ko, K Palmer… - British journal of …, 2021 - nature.com
Background Using an updated dataset with more patients and extended follow-up, we
further established cancer patient characteristics associated with COVID-19 death. Methods …
further established cancer patient characteristics associated with COVID-19 death. Methods …
[HTML][HTML] Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the …
Background The medium-term and long-term impact of COVID-19 in patients with cancer is
not yet known. In this study, we aimed to describe the prevalence of COVID-19 sequelae …
not yet known. In this study, we aimed to describe the prevalence of COVID-19 sequelae …
[HTML][HTML] Factors affecting COVID-19 outcomes in cancer patients: a first report from guy's cancer center in London
B Russell, C Moss, S Papa, S Irshad, P Ross… - Frontiers in …, 2020 - frontiersin.org
Background: There is insufficient evidence to support clinical decision-making for cancer
patients diagnosed with COVID-19 due to the lack of large studies. Methods: We used data …
patients diagnosed with COVID-19 due to the lack of large studies. Methods: We used data …
[HTML][HTML] Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study
Background Despite high contagiousness and rapid spread, severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has led to heterogeneous outcomes across affected …
syndrome coronavirus 2 (SARS-CoV-2) has led to heterogeneous outcomes across affected …
[HTML][HTML] Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score
GM Dettorre, S Dolly, A Loizidou, J Chester… - … for ImmunoTherapy of …, 2021 - ncbi.nlm.nih.gov
Background Patients with cancer are particularly susceptible to SARS-CoV-2 infection. The
systemic inflammatory response is a pathogenic mechanism shared by cancer progression …
systemic inflammatory response is a pathogenic mechanism shared by cancer progression …
COVID-19 sequelae and the host proinflammatory response: an analysis from the OnCovid registry
A Cortellini, A Gennari, F Pommeret… - JNCI: Journal of the …, 2022 - academic.oup.com
Background Fifteen percent of patients with cancer experience symptomatic sequelae,
which impair post–COVID-19 outcomes. In this study, we investigated whether a …
which impair post–COVID-19 outcomes. In this study, we investigated whether a …